Retina International

Call Directions Website Contact the practice

Retina International A global umbrella organisation for patient led charities
RCN: 20206322 Registered Charity Number (RCN) 20206322

Diabetes care should include eye care.This World Diabetes Day, we're highlighting the importance of recognising and addr...
14/11/2026

Diabetes care should include eye care.

This World Diabetes Day, we're highlighting the importance of recognising and addressing the impact diabetes can have on eye health.

Diabetes-related retinal conditions, including diabetic retinopathy and diabetic macular oedema (DME), can affect vision and, without appropriate care, may lead to sight loss. Regular eye examinations, early detection and timely access to screening and treatment are important in helping protect vision.

Check out our new website, where we have included the latest information about diabetes-related eye conditions and their impact on vision.

🔗 https://retina-international.org/retinal-conditions/age-related-acquired/diabetes-related-retinal-conditions/

And listen to our In Focus podcast, where Retina International CEO Avril Daly speaks with Professor David Keegan, consultant ophthalmologist and member of RI's Scientific and Medical Advisory Board. They discuss how diabetes affects the eyes, the importance of early detection, diabetic eye screening and available treatments to help preserve sight.

https://retina-international.org/podcasts/in-focus-series-2-2/

This World Diabetes Day, let's keep eye health part of the conversation. Because access to diabetes care must also mean access to the eye care that helps protect vision.



[ID: Graphic for World Diabetes Day 2026, featuring an eye-care icon and a blue awareness ribbon. Text highlights the importance of including eye care as part of diabetes care.]

12/11/2026

"The EU Presidency is about more than hosting events. It's about shaping Europe's future and delivering real benefits for patients across the continent."

Ireland hosting the EU Presidency is about more than events and welcoming European leaders. It's about bringing countries together to shape priorities, influence policy and drive progress on issues that matter to people across Europe.

Speaking to Andrea Gilligan on Newstalk about the importance of Ireland hosting the EU Presidency, our CEO, Avril Daly, highlighted how sustained collaboration between successive Presidencies has helped advance the European agenda on rare diseases and joint clinical assessment.

The impact goes far beyond six months, it’s about creating opportunities for lasting change for patients and communities across Europe.

Listen to the full contribution here: https://www.newstalk.com/listen-back



[Video Description: A dark blue background featuring a large white microphone icon surrounded by audio waveforms and a starry background. RI logo in bottom-left corner, while a promotional image for Lunchtime Live with Andrea Gilligan on Newstalk is displayed on the right.]

The impact of Thyroid Eye Disease (TED) extends beyond the eyes, affecting the whole person and their quality of life.Th...
12/11/2026

The impact of Thyroid Eye Disease (TED) extends beyond the eyes, affecting the whole person and their quality of life.

This TED Awareness Week, we're highlighting the importance of whole-person care and ensuring that the experiences, needs and priorities of people living with TED are heard and understood.

Whole-person care recognises that living with a condition can affect many aspects of life, from physical health and emotional wellbeing to relationships, confidence, daily activities and access to support. Understanding these experiences is essential to developing care pathways and support systems that respond to what matters most to people.

In collaboration with the University of Canberra, we are conducting a qualitative research study to better understand the lived experiences of people with TED. Through individual interviews, we want to hear directly from people about their experiences, challenges, needs and priorities, and what whole-person care means to them.

If you live with TED, we would love to hear from you.

We are inviting adults aged 18 and over living with TED in Europe (including the UK) and Australia to take part in an online interview lasting approximately 60-70 minutes.

Your experience can help inform future research, treatments, care pathways and support systems.

Contact Kate Fankun Cao at [email protected].

Find out more about the study: https://retina-international.org/share-your-experience-of-living-with-thyroid-eye-disease-ted/

This TED Awareness Week, let's make space for the conversations that matter, because better care starts with listening.



[ID: A graphic for TED Awareness Week highlighting the wider impact of Thyroid Eye Disease on quality of life. It invites people living with TED to share their experiences by taking part in Retina International’s research study.]

Our new website is officially live!We are delighted to welcome you to the new online home for Retina International.This ...
05/11/2026

Our new website is officially live!

We are delighted to welcome you to the new online home for Retina International.

This has been a huge collaborative project, and our aim throughout has been to create an online space that is more accessible, easier to navigate, and packed with useful, up-to-date information and resources for our global retina community.

But this website wasn't built in isolation. It has been shaped by our members and wider connections who make up our retina community.

To everyone who took part in our focus groups, completed surveys, shared feedback, joined discussions, tested features, reviewed content or contributed in any way along the journey: Thank You!

Every suggestion, comment and conversation helped us make this website better.

Now, we'd love for you to explore it!

🔗 Visit the Retina International website: www.retina-international.org

Explore and discover the updated resources and information, and let us know what you think.

We would genuinely love to hear your feedback, ideas and suggestions as we continue to improve and develop the website.

This marks an exciting new chapter for Retina International, and we're so happy to finally share it with you!

Retina International (RI) is a patient-led, global, umbrella NGO for patient-led groups around the world focused on research and support for rare and common retinal diseases.

29/10/2026

Retina International Board Chair Franz Badura congratulates Professor Peter Hegemann, one of the three recipients of the 2026 Nobel Prize in Physiology or Medicine, on behalf of the global retina community.

Peter shares the Nobel Prize with Karl Deisseroth and Georg Nagel for their pioneering discoveries in optogenetics, a technique that uses light to control cell activity, transforming neuroscience and opening new avenues for therapeutic research, including approaches to restoring vision.

We extend our warmest congratulations to Peter Hegemann, Karl Deisseroth and Georg Nagel on this outstanding recognition. Their achievement reminds us how fundamental scientific discoveries can open doors to new possibilities, and why continued collaboration among researchers, clinicians, and the patient community matters.



[Video description: Video featuring Franz Badura, Board Chair of Retina International, in conversation with Professor Peter Hegemann, 2026 Nobel Prize laureate in Physiology or Medicine. Franz congratulates Peter on behalf of Retina International, and they discuss the future of therapeutics. Peter also sends his best wishes to his colleagues, Professor José-Alain Sahel, Chair of Retina International’s Scientific and Medical Advisory Board, and Professor Botond Roska, on their contributions to therapeutic research.]

Two days of big ideas, bold conversations and seriously galvanising energy at the first-ever EPF Youth Congress 2026 in ...
28/10/2026

Two days of big ideas, bold conversations and seriously galvanising energy at the first-ever EPF Youth Congress 2026 in Brussels!

Our Membership and Engagement Coordinator, Navya Dhir, alongside Claudio Orlando from Pro Retina Deutschland, joined young patient advocates and changemakers to explore what it takes to secure the future of youth advocacy in times of multiple crises.

From climate change and health equity to social protection, meaningful patient involvement and young people’s place in health policy, the conversations were a reminder that youth advocacy is not simply about giving young people a seat at the table, it’s also about making sure they have the space, support and influence to shape what happens next.

We got the opportunity to hear from inspiring speakers, including Ivett Jakab, Agata Cybulska, Natalie Pidmurniak and Jana Hlaváčová, and connect with people bringing fresh perspectives and ideas to patient advocacy across Europe.

A huge thank you to the European Patients’ Forum and the EPF Youth Group for creating a space like this that felt genuinely ambitious, vibrant and full of possibility.

We’re coming away with plenty to think about, new connections and one clear takeaway: be willing to challenge the status quo, take action, and make some noise 💥



1: A photo of the audience attending a session at the EPF Youth Congress, with speakers on stage and presentations on screen.
2: Navya Dhir and Claudio Orlando in front of the EPF Youth Congress backdrop.
3: Navya taking a selfie with Claudio Orlando, Ivett Jakab, former President of the EPF Youth Group, and Anja from the EPF Team.
4: Navya points to Ivett's T-shirt, which reads, “I may be a patient advocate but don’t test my patience.”
5: Navya stands beside a display about the Youth Involvement in Patient Organisations course.

We are deeply encouraged by Opus Genetics' FDA clearance to begin clinical development of OPGx-RDH12, an investigational...
22/10/2026

We are deeply encouraged by Opus Genetics' FDA clearance to begin clinical development of OPGx-RDH12, an investigational gene therapy for RDH12-associated childhood blindness, developed in collaboration with patient organisations to advance a potential treatment for this rare inherited retinal disease.

This is a major milestone for the retina community. By bringing patient organisations and researchers together to share funding, knowledge and risks, this collaborative approach is helping advance research towards potential treatments. Putting families at the heart of research helps ensure their needs and experiences are heard and could inspire other rare disease communities to follow a similar path.

We know how tirelessly Silvia Cerolini has worked for this moment.

Well done, Silvia, Eyes on the Future, RDH12 Fund for Sight and all at the Global RDH12 Alliance and Opus Genetics on this important achievement!

➡️ https://ir.opusgtx.com/press-releases/detail/547/opus-genetics-announces-fda-clearance-of-ind-application-for-opgx-rdh12-gene-therapy-for-inherited-childhood-blindness



[ID: FDA clearance has been granted to begin clinical development of OPGx-RDH12, an investigational gene therapy for RDH12-associated childhood blindness. The graphic highlights progress in research through patient–researcher collaboration.]

Health research needs your perspective 💬How can patients, carers and members of the public help shape the evidence that ...
20/10/2026

Health research needs your perspective 💬

How can patients, carers and members of the public help shape the evidence that informs healthcare decisions?

Evidence Synthesis Ireland is offering a free six-week online course for anyone interested in learning about evidence synthesis and how to get involved. Evidence syntheses bring together findings from multiple studies to help us understand what research tells us, informing health policies, clinical guidelines and personal health decisions.

You do not require any research experience, just an interest in learning and contributing your perspective!

Course starts: 2nd November 2026
Eligibility: Members of the public, patients, carers, family members currently resident of Ireland & Northern Ireland

Register your interest by: 27th October 2026

Register your interest here: https://us.list-manage.com/15z9TGyI4bR?e=5071c80469&c2id=65e8ca394c19ffee81a0adf36f5170d2



[ID: Evidence Synthesis Ireland is offering a free six-week online course starting 2 November for patients, carers, family members and the public in Ireland and Northern Ireland. Register your interest by 27 October to learn how research evidence is reviewed and how to get involved.]

The European Medicines Agency has opened a consultation for a draft concept paper exploring the need for dedicated guida...
19/10/2026

The European Medicines Agency has opened a consultation for a draft concept paper exploring the need for dedicated guidance on the clinical investigation of medicines intended to treat Inherited Retinal Dystrophies ( ).

Why does this matter?
Appropriate guidance can help shape how potential treatments are studied and evaluated, making it important that the needs and experiences of people living with inherited retinal conditions are considered in these discussions.

As a global alliance of patient-led organisations, we recognise the importance of bringing the patient perspective into research and regulatory processes. We plan to contribute to this consultation.

Deadline for submissions: 31st January 2027

🔗 Read the draft concept paper and learn more about the consultation:
https://ow.ly/QBUc50ZYmg1



[ID: Graphic for announcement - EMA consultation on clinical guidelines for inherited retinal dystrophies, with a feedback deadline of 31 January 2027 and a QR code linking to the draft concept paper.]

It’s been a month since the Retina International World Youth Conference 2026, and we’re still carrying the conversations...
16/10/2026

It’s been a month since the Retina International World Youth Conference 2026, and we’re still carrying the conversations, ideas and the spirit of community forward.

With 130+ registrations across 34+ countries and 12 speakers across two sessions, RIYC 2026 brought young voices together to talk about mental health, AI and assistive technology, lived experience, advocacy and the power of community.

A huge thank you to everyone who joined us, shared their perspectives, asked questions and helped make this conference what it was.

And as we shared during the conference, we’re only getting started!

We want to keep creating spaces for young people living with retinal conditions to connect, share experiences, exchange ideas and help shape what comes next.

If you would like to be part of the next chapter, please sign up through this form to hear about future youth activities and opportunities to get involved - https://forms.gle/a711bo3yfAGmn4oTA

And if you missed it, catch the full recording of RIYC 2026 on our official YouTube channel - https://youtu.be/ojdguuCE3Bg?si=hz_VUH2262kVhmUr



[ID: Retina International World Youth Conference 2026 highlights: 130+ registrations, 34+ countries, 12 speakers and two sessions, with more to come.]

Address

12 Camden Row, Dublin 8
Dublin
D08FP38

Alerts

Be the first to know and let us send you an email when Retina International posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Retina International:

Shortcuts

Sponsored

Share